Overexcited neurons not good for cell healthDecember 18, 2007EVANSTON, Ill. --- Neurotransmitters have consequences. They initiate events that are critical to a healthy life, giving us the ability to move, to talk, to breathe, to think. But that's if the neurotransmitters are getting it right and sending proper signals downstream to muscle cells, neurons or other cells. Now a Northwestern University study reports that a mutation in a transcription factor that controls a neurotransmitter in the nematode C. elegans causes an imbalance in neuronal signaling that results in protein damage in target cells. Similar results and consequences on protein folding were found to occur upon exposure to the common toxins nicotine and lindane (a pesticide). Whether due to genetic mutation or exposure to small molecules, the neurons become overexcited and fire incorrect signals too rapidly, resulting in proteins in target muscle cells becoming stressed, misfolding and becoming non-functional. "To find that small molecules reproduce our genetic observations -- that both environment and genetics cause a molecular defect in the ability of proteins to function in muscle cells -- was not expected," said Richard I. Morimoto, Bill and Gayle Cook Professor of Biochemistry, Molecular Biology and Cell Biology in Northwestern's Weinberg College of Arts and Sciences, who led the research team. This study provides some of the strongest evidence that nerve cell activity can directly affect the protein folding process in another cell. (Muscle cells in the case of this study.) Many different diseases and conditions, such as many neurodegenerative diseases, certain cancers, muscular dystrophy and the aging process, cause loss of muscle cell function. How that happens is not well understood. "We may have discovered an unexpected basis for a number of human diseases," said Morimoto. "Particularly interesting is the link with the environment. We've shown that pesticides, which are widespread and have been linked to an increase in Parkinson's disease and other neurodegenerative diseases among farmers, have profound effects on nerve communication -- even more than we expected." "Neuronal Signaling Modulates Protein Homeostasis in Caenorhabditis Elegans Post-synaptic Muscle Cells" is published by the journal Genes & Development. In addition to Morimoto, the study's co-investigators include lead author Susana M. Garcia, a former graduate student of Morimoto's and now a postdoctoral fellow at Harvard University; M. Olivia Casanueva, a postdoctoral fellow, and M. Catarina Silva, a visiting predoctoral student, both at Northwestern; and Margarida D. Amaral, University of Lisbon, Portugal. Morimoto and his team studied presynaptic neurons and postsynaptic muscle cells in C. elegans, a transparent roundworm whose biochemical environment is similar to that of human beings and whose genome, or complete genetic sequence, is known. Specifically, the researchers looked at what happened to polyglutamine proteins in muscle cells that were at the tipping point: the proteins were at risk of soon aggregating and losing their function. The scientists wanted to see if they could cause the protein, which is associated with Huntington's disease, to show its toxicity prematurely. (If misfolded or damaged proteins accumulate beyond a certain critical point, they aggregate and disease can result. ) In separate experiments, the researchers induced two genetic mutations in presynaptic neurons, one that caused the reduction of the neurotransmitter GABA, which inhibits neuronal firing, and one that increases the action of a neurotransmitter called acetylcholine, which stimulates neuronal firing. The result of both mutations was overexcited neurons that disrupted the way the neurons sent signals to the muscle cells and caused protein aggregation. The effects were similar when the researchers introduced both nicotine (a neurostimulant) and lindane (an inhibitor of GABA, causing overstimulated neurons) to neurons with no mutations. "Neurons integrate information and transfer this information to surrounding cells, influencing protein homeostasis," said Morimoto, an expert on Huntington's disease, amyotrophic lateral sclerosis (ALS) and the cellular and molecular response to damaged proteins. "When a neuron's electrochemistry is imbalanced every cell downstream is imbalanced. We've revealed that it's an integrated communications network that determines protein folding." While Morimoto and his team focused only on postsynaptic muscle cells in this study, they plan to look at other cells and how neuronal signaling affects their function. Northwestern University |
|||||||||||||||||||||
| Related Neurotransmitter Current Events and Neurotransmitter News Articles Researchers begin to decipher metabolism of sexual assault drug It's a naturally occurring brain chemical with an unwieldy name: 4-hydroxybutyrate (4-HB). Taken by mouth, it can be abused or used as a date-rape drug. New Down syndrome treatment suggested by Stanford/Packard study in mice At birth, children with Down syndrome aren't developmentally delayed. But as they age, these kids fall behind. Memory deficits inherent in Down syndrome hinder learning, making it hard for the brain to collect experiences needed for normal cognitive development. Cognitive dysfunction reversed in mouse model of Down syndrome A study by neuroscientist William C. Mobley, MD, PhD, chair of the Department of Neurosciences at the University of California, San Diego School of Medicine, and colleagues at Stanford University Medical School has demonstrated a possible new approach to slowing the inevitable progression of cognitive decline found in Down's syndrome. CSHL team solves structure of NMDA receptor unit that could be drug target for neurological diseases A team of scientists at Cold Spring Harbor Laboratory (CSHL) reports on Thursday their success in solving the molecular structure of a key portion of a cellular receptor implicated in Alzheimer's, Parkinson's, and other serious illnesses. Mood improves on low-fat, but not low-carb, diet plan After one year, a low-calorie, low-fat diet appears more beneficial to dieters' mood than a low-carbohydrate plan with the same number of calories. BUSM researchers show dieters can experience neurobiological similarities of drug addicts Researchers from Boston University School of Medicine (BUSM) have shown that intermittent access to foods rich in fat and sugar induces changes in the brain which are comparable to those observed in drug dependence. Scripps team shows diet switching can activate brain's stress system, lead to 'withdrawal' symptoms In research that sheds light on the perils of yo-yo dieting and repeated bouts of sugar-bingeing, researchers from The Scripps Research Institute have shown in animal models that cycling between periods of eating sweet and regular-tasting food can activate the brain's stress system and generate overeating, anxiety, and withdrawal-like symptoms. Widely used cholesterol-lowering drug may prevent progression Simvastatin, a commonly used, cholesterol-lowering drug, may prevent Parkinson's disease from progressing further. Neurological researchers at Rush University Medical Center conducted a study examining the use of the FDA-approved medication in mice with Parkinson's disease and found that the drug successfully reverses the biochemical, cellular and anatomical changes caused by the disease. Benefit of memantine in the treatment of Alzheimer's disease not proven There is no scientific proof that patients with moderate or severe Alzheimer's disease benefit from drugs containing the agent memantine. Changes in brain chemicals mark shifts in infant learning When do you first leave the nest? Early in development infants of many species experience important transitions-such as learning when to leave the protective presence of their mother to start exploring the wider world. More Neurotransmitter Current Events and Neurotransmitter News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||